Switching directly from emicizumab to Mim8 is safe and well-tolerated in patients with hemophilia A, with or without inhibitors.

Since his initial consultation, the patient has had a negative cold agglutinin titer. Discussion Chilblain lupus erythematosus is an uncommon skin condition.

A rare case has been reported of diffuse large B-cell lymphoma (DLBCL) presenting initially as cold agglutinin disease (CAD). The report, published in the Kaohsiung Journal of Medical Sciences ...

William J. Tulloch, A Study of the Mechanism of the Agglutination and Absorption of Agglutinin Reaction, Together with an Examination of the Efficacy of These Tests for Identifying Specimens of the ...

Recordati is acquiring Sanofi’s Enjaymo, the only approved drug for the rare blood disorder cold agglutinin disease. Achieving sales milestones could bring the deal’s value to more than $1 ...

This satellite symposium was organised and sponsored by Sanofi and is intended for healthcare professionals only. Speakers were compensated for their participation at this event. Watch this EHA2024 ...

Physicians presented the case report of a patient with cold agglutinin disease who experienced an acute exacerbation due to COVID-19 infection. In the Annals of Internal Medicine Clinical Cases, ...

Secondly, we maintain that there are currently more effective therapies than TPE in patients developing cold agglutinin disease, with several additional drugs, including upstream complement inhibitors ...

Answer: Cold agglutinin disease is a specific type of anemia where antibodies attack and destroy a person's own red blood cells. Unlike the usual type of autoimmune hemolytic ("hemolytic" means ...